U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C9H13NO
Molecular Weight 151.2056
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GEPEFRINE

SMILES

C[C@H](N)CC1=CC(O)=CC=C1

InChI

InChIKey=WTDGMHYYGNJEKQ-ZETCQYMHSA-N
InChI=1S/C9H13NO/c1-7(10)5-8-3-2-4-9(11)6-8/h2-4,6-7,11H,5,10H2,1H3/t7-/m0/s1

HIDE SMILES / InChI

Molecular Formula C9H13NO
Molecular Weight 151.2056
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Gepefrine (Pressionorm and Wintonin) is an antihypotensive agent. It was used for therapy of orthostatic dysregulation. One hour after oral administration of 30 mg or 45 mg gepefrine the blood pressure increased significantly at rest and more markedly on standing and during the step test. Gepefrine led to a reduction in pathological orthostatic regulation during the early phase as well as to the prevention of subjective and objective signs of orthostatic adjustment disorder during the late phase. Patients with insufficient rise in blood pressure during the step test (80 watts) showed after gepefrine a distinct tendency towards normalisation and the regression of subjective states of exhaustion. Gepefrine caused on average no substantive alternations in heart rate during all phases of the investigation. Complications or side-effects due to the method or the medicament were not observed.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
PubMed

PubMed

TitleDatePubMed
[Therapy of orthostatic dysregulation. Comparative studies on anti-hypotensive sympathomimetics with a tilt-table test].
1980 Aug 7
[Therapy of orthostatic dysregulation with gepefrin. Study with continuous telemetric blood pressure monitoring].
1985 Apr
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: The action of the pressor agent gepefrine (D form of 3-hydroxyphenyl-2-aminopropan) was evaluated in 16 patients with typical clinical symptoms of orthostatic adjustment disorders
One hour after oral administration of 30 mg or 45 mg gepefrine the blood pressure increased significantly at rest and more markedly on standing and during the step test.
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:06:05 UTC 2023
Edited
by admin
on Fri Dec 15 16:06:05 UTC 2023
Record UNII
V51RRX51VH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GEPEFRINE
INN   MI   WHO-DD  
INN  
Official Name English
PHENOL, 3-(2-AMINOPROPYL)-, (S)-
Systematic Name English
gepefrine [INN]
Common Name English
PHENOL, M-(2-AMINOPROPYL)-, (S)-(+)-
Common Name English
Gepefrine [WHO-DD]
Common Name English
D-.ALPHA.-METHYL-M-TYRAMINE
Common Name English
GEPEFRINE [MI]
Common Name English
(.ALPHA.-S)-(+)-.ALPHA.-METHYL-M-TYRAMINE
Common Name English
(+)-(S)-M-(2-AMINOPROPYL)PHENOL
Systematic Name English
PHENOL, 3-((2S)-2-AMINOPROPYL)-
Systematic Name English
Classification Tree Code System Code
WHO-ATC C01CA15
Created by admin on Fri Dec 15 16:06:05 UTC 2023 , Edited by admin on Fri Dec 15 16:06:05 UTC 2023
NCI_THESAURUS C29709
Created by admin on Fri Dec 15 16:06:05 UTC 2023 , Edited by admin on Fri Dec 15 16:06:05 UTC 2023
WHO-VATC QC01CA15
Created by admin on Fri Dec 15 16:06:05 UTC 2023 , Edited by admin on Fri Dec 15 16:06:05 UTC 2023
Code System Code Type Description
EPA CompTox
DTXSID60172191
Created by admin on Fri Dec 15 16:06:05 UTC 2023 , Edited by admin on Fri Dec 15 16:06:05 UTC 2023
PRIMARY
FDA UNII
V51RRX51VH
Created by admin on Fri Dec 15 16:06:05 UTC 2023 , Edited by admin on Fri Dec 15 16:06:05 UTC 2023
PRIMARY
SMS_ID
100000084541
Created by admin on Fri Dec 15 16:06:05 UTC 2023 , Edited by admin on Fri Dec 15 16:06:05 UTC 2023
PRIMARY
NCI_THESAURUS
C72920
Created by admin on Fri Dec 15 16:06:05 UTC 2023 , Edited by admin on Fri Dec 15 16:06:05 UTC 2023
PRIMARY
EVMPD
SUB07896MIG
Created by admin on Fri Dec 15 16:06:05 UTC 2023 , Edited by admin on Fri Dec 15 16:06:05 UTC 2023
PRIMARY
RXCUI
41157
Created by admin on Fri Dec 15 16:06:05 UTC 2023 , Edited by admin on Fri Dec 15 16:06:05 UTC 2023
PRIMARY RxNorm
MESH
C045355
Created by admin on Fri Dec 15 16:06:05 UTC 2023 , Edited by admin on Fri Dec 15 16:06:05 UTC 2023
PRIMARY
DRUG BANK
DB13703
Created by admin on Fri Dec 15 16:06:05 UTC 2023 , Edited by admin on Fri Dec 15 16:06:05 UTC 2023
PRIMARY
DRUG CENTRAL
1290
Created by admin on Fri Dec 15 16:06:05 UTC 2023 , Edited by admin on Fri Dec 15 16:06:05 UTC 2023
PRIMARY
PUBCHEM
219105
Created by admin on Fri Dec 15 16:06:05 UTC 2023 , Edited by admin on Fri Dec 15 16:06:05 UTC 2023
PRIMARY
INN
4270
Created by admin on Fri Dec 15 16:06:05 UTC 2023 , Edited by admin on Fri Dec 15 16:06:05 UTC 2023
PRIMARY
MERCK INDEX
m1177
Created by admin on Fri Dec 15 16:06:05 UTC 2023 , Edited by admin on Fri Dec 15 16:06:05 UTC 2023
PRIMARY Merck Index
ChEMBL
CHEMBL2105064
Created by admin on Fri Dec 15 16:06:05 UTC 2023 , Edited by admin on Fri Dec 15 16:06:05 UTC 2023
PRIMARY
CAS
18840-47-6
Created by admin on Fri Dec 15 16:06:05 UTC 2023 , Edited by admin on Fri Dec 15 16:06:05 UTC 2023
PRIMARY
Related Record Type Details
RACEMATE -> ENANTIOMER
Related Record Type Details
ACTIVE MOIETY